-
Je něco špatně v tomto záznamu ?
Bioinformatic analysis of miRNAs targeting the key nuclear receptors regulating CYP3A4 gene expression: The challenge of the CYP3A4 “missing heritability” enigma
Tomas Smutny, Jurjen Duintjer Tebbens, Petr Pavek
Jazyk angličtina Země Česko
Typ dokumentu práce podpořená grantem
- Klíčová slova
- jaderné receptory regulující expresi genu CYP3A4,
- MeSH
- biotransformace genetika imunologie účinky léků MeSH
- cytochrom P-450 CYP3A farmakologie genetika účinky léků MeSH
- farmakogenetika metody trendy MeSH
- genetický výzkum MeSH
- individualizovaná medicína metody trendy MeSH
- lidé MeSH
- mikro RNA * farmakologie genetika imunologie MeSH
- regulace genové exprese * genetika imunologie MeSH
- systém (enzymů) cytochromů P-450 genetika účinky léků MeSH
- výpočetní biologie metody trendy MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
The expression of the main cytochrome P450 enzyme CYP3A4 displays enormous interindividual variability. Studies addressing the genetic variability of either the CYP3A4 gene itself or its key transcription factors have not found any crucial polymorphism contributing to this variability in expression, a phenomenon is referred to as the “missing heritability of CYP3A4 variability.” Several reports have recently described microRNAs (miRNAs) targeting the CYP3A4 gene and/or its major transcription factors. A comprehensive bioinformatic analysis was performed using the miRDB, PITA, miRanda and TargetScan programs in the search for hypothetical miRNAs targeting 3′-untranslated regions of PXR, CAR, VDR, HNF4α, RXRα, SHP and GRα genes controlling CYP3A4 expression. We propose several novel miRNAs identified parallelly by at least three algorithms to the target analyzed genes. In particular, we found novel promising miRNAs which may be involved in the indirect PXR-mediated CYP3A4 gene expression such as miR-18a and miR-18b, miR-449a, miR-449b and miR-34a. We also hypothesize that some miRNAs may play the role of a master regulator of NRs since they are predicted to target more than three genes. The identification of miRNAs determining CYP3A4 interindividual variability might be an important step toward progress in pharmacogenetics and personalized medicine.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15030010
- 003
- CZ-PrNML
- 005
- 20160128132400.0
- 007
- ta
- 008
- 150921s2015 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2015.04.002 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Smutný, Tomáš $7 _AN077737 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove CZ-500 05, Czech Republic
- 245 10
- $a Bioinformatic analysis of miRNAs targeting the key nuclear receptors regulating CYP3A4 gene expression: The challenge of the CYP3A4 “missing heritability” enigma / $c Tomas Smutny, Jurjen Duintjer Tebbens, Petr Pavek
- 504 __
- $a Literatura
- 520 9_
- $a The expression of the main cytochrome P450 enzyme CYP3A4 displays enormous interindividual variability. Studies addressing the genetic variability of either the CYP3A4 gene itself or its key transcription factors have not found any crucial polymorphism contributing to this variability in expression, a phenomenon is referred to as the “missing heritability of CYP3A4 variability.” Several reports have recently described microRNAs (miRNAs) targeting the CYP3A4 gene and/or its major transcription factors. A comprehensive bioinformatic analysis was performed using the miRDB, PITA, miRanda and TargetScan programs in the search for hypothetical miRNAs targeting 3′-untranslated regions of PXR, CAR, VDR, HNF4α, RXRα, SHP and GRα genes controlling CYP3A4 expression. We propose several novel miRNAs identified parallelly by at least three algorithms to the target analyzed genes. In particular, we found novel promising miRNAs which may be involved in the indirect PXR-mediated CYP3A4 gene expression such as miR-18a and miR-18b, miR-449a, miR-449b and miR-34a. We also hypothesize that some miRNAs may play the role of a master regulator of NRs since they are predicted to target more than three genes. The identification of miRNAs determining CYP3A4 interindividual variability might be an important step toward progress in pharmacogenetics and personalized medicine.
- 650 22
- $a výpočetní biologie $x metody $x trendy $7 D019295
- 650 12
- $a regulace genové exprese $x genetika $x imunologie $7 D005786
- 650 12
- $a mikro RNA $x farmakologie $x genetika $x imunologie $7 D035683
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x genetika $x účinky léků $7 D003577
- 650 _2
- $a cytochrom P-450 CYP3A $x farmakologie $x genetika $x účinky léků $7 D051544
- 650 _2
- $a farmakogenetika $x metody $x trendy $7 D010597
- 650 _2
- $a individualizovaná medicína $x metody $x trendy $7 D057285
- 650 _2
- $a genetický výzkum $7 D036281
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a biotransformace $x genetika $x imunologie $x účinky léků $7 D001711
- 653 20
- $a jaderné receptory regulující expresi genu CYP3A4
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Tebbens, Jurjen Duintjer $7 _AN084306 $u Department of Biophysics and Physical Chemistry, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove CZ-500 05, Czech Republic
- 700 1_
- $a Pávek, Petr $7 xx0093070 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove CZ-500 05, Czech Republic
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 13, č. 3 (2015), s. 181-188 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2015/03/02.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20150522215938 $b ABA008
- 991 __
- $a 20160128132519 $b ABA008
- 999 __
- $a ok $b bmc $g 1090901 $s 913103
- BAS __
- $a 3
- BMC __
- $a 2015 $b 13 $c 3 $d 181-188 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK184 $d 20160127 $a NLK 2015-40/dk